Skip to main content

Table 3 Significant patient-reported outcome predictors of adherence to supervised exercise in the CARE Trial, 2008–2011, Canada

From: Predictors of adherence to different types and doses of supervised exercise during breast cancer chemotherapy

   Correlation1 ANOVA2
Variable M ± SD (%) r; p value F; p value
Physical well-being   .12; 0.036 2.5; 0.081
 < 23 (n = 98) 69% ± 24%   
 23-25.9 (n = 93) 74% ± 25%   
 ≥ 26 (n = 110) 76% ± 24%   
Taxane/neuropathy symptoms   .17; .003 3.2; 0.043
 < 61 (n = 83) 68% ± 25%   
 61-63 (n = 102) 73% ± 24%   
 64 (n = 116) 77% ± 23%   
Endocrine symptoms   .17; 0.003 1.5; 0.21
 ≤ 65 (n = 104) 70% ± 24%   
 66-71 (n = 99) 74% ± 23%   
 > 71 (n = 98) 75% ± 25%   
  1. Note. 1Tested the association as a continuous variable. 2Tested the association as a predefined categorical variable.